UNSPSC 51393100: Sympathomimetic or adrenergic quinolines

This classification denotes Sympathomimetic or adrenergic drugs made from compounds consisting of a catabolite of tryptophan.

UNSPSC 51393100 Sympathomimetic or adrenergic quinolines is a Class code under which state and local governments procure emergency-response pharmaceuticals, including naloxone (opioid reversal agents) and related drug-management systems. The code captures public health and safety initiatives driven by county health departments and state health agencies addressing overdose response and controlled-substance management. Recent solicitations show demand for both unit purchases of ready-to-use naloxone kits and integrated drug deactivation systems, with vendors responsible for managing supply-chain logistics including delivery, storage compliance, and quarterly or scheduled replenishment cycles.

Activity under this code is concentrated in counties and state health agencies managing opioid-response programming. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through its competitive bidding process, with quarterly deliveries to the Seminole County Community Health Building and a response deadline of July 26, 2023. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026 to gather vendor intelligence on direct-to-manufacturer prescription fulfillment capabilities, signaling that states are exploring streamlined procurement models beyond traditional pharmacy benefit managers. Geographic activity is evident in Florida and Texas; no other states appear in the recent-opportunities block. Vendors pursuing this code should expect multi-year contracts with renewal options, fixed-fee pricing models, standard compliance requirements (drug-free workplace, E-Verify, liability insurance), and in some cases FEMA-related federal compliance obligations.